B. Weber

ifosfamide, and cisplatin (see comments) stimulating factor following polychemotherapy with etoposide, administration of interleukin-3 and granulocyte-macrophage colony- Mobilization of peripheral blood progenitor cells by sequential

L. Kanz, W. Brugger, R. Mertelsmann, 2011 .

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.

L. Kanz, W. Brugger, R. Mertelsmann, 1992, Blood.

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial.

J. Bonneterre, L. Mauriac, P. Fargeot, 1988, European journal of cancer & clinical oncology.

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact.

F. Penault-Llorca, N. Radosevic-Robin, T. Petit, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial.

B. Weber, P. Fumoleau, L. Vanlemmens, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Double-blind Randomised Placebo-controlled Phase III Study of an E. coli Extract plus 5-Fluorouracil versus 5-Fluorouracil in Patients with Advanced Colorectal Cancer

B. Schneider, C. Unger, S. Hockertz, 2001, Arzneimittelforschung.